Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol via Nebulizer vs pMDI for Methacholine-Induced Bronchoconstriction
NCT05977699Phase 4Completed
- Sponsor
- University of Saskatchewan
- Start
- Jan 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol in asthma, sponsored by University of Saskatchewan. Started Jan 2024; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05977699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05977699.